Remepy is pioneering hybrid drugs, and redefining combination therapy. Our mission is to bring better personalized care to patients.
Board Member
Former prime minister of Israel and serial entrepreneur.
Board Member
Global Head of Research & Development and Chief Medical Officer at Merck.
Scientific Advisor
Professor of Neuroimmunology at the Weizmann Institute of Science, responsible for discovery of the key role of the immune system in brain function and repair.
Industry Advisor
Digital health expert, investor, and board member. Formerly the Chief Digital Officer at Bayer and currently board member at Sage Therapeutics (SAGERX).
Industry Advisor
Serial life science and healthcare entrepreneur, executive and venture capitalist.
Scientific Advisor
Director of the Women's Health Innovation Center, Deputy Chief Transformation Officer at Sheba Tel Hashomer Hospital.